Prescription and Over-the-Counter Drug Product List 39TH EDITION Cumulative Supplement Number 02 : February 2019 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ABIRATERONE ACETATE TABLET;ORAL ABIRATERONE ACETATE >A> AB RISING PHARMS 250MG A 208371 001 Feb 25, 2019 Feb NEWA >A> AB WOCKHARDT BIO AG 250MG A 208380 001 Feb 27, 2019 Feb NEWA ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE TABLET;ORAL APADAZ >D> + KEMPHARM 325MG;EQ 4.08MG BASE N 208653 002 Jan 04, 2019 Feb CAHN >D> + 325MG;EQ 6.12MG BASE N 208653 001 Feb 23, 2018 Feb CAHN >D> + 325MG;EQ 8.16MG BASE N 208653 003 Jan 04, 2019 Feb CAHN >A> + KVK TECH INC 325MG;EQ 4.08MG BASE N 208653 002 Jan 04, 2019 Feb CAHN >A> + 325MG;EQ 6.12MG BASE N 208653 001 Feb 23, 2018 Feb CAHN >A> + 325MG;EQ 8.16MG BASE N 208653 003 Jan 04, 2019 Feb CAHN ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION;ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> AA WES PHARMA INC 325MG/15ML;7.5MG/15ML A 211023 001 Mar 08, 2019 Feb NEWA ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE;ORAL ACETAZOLAMIDE >A> AB ALEMBIC PHARMS LTD 500MG A 210423 001 Feb 19, 2019 Feb NEWA ACYCLOVIR CREAM;TOPICAL ZOVIRAX >A> AB +! BAUSCH 5% N 021478 001 Dec 30, 2002 Feb CAHN >D> AB +! VIB 5% N 021478 001 Dec 30, 2002 Feb CAHN OINTMENT;TOPICAL ACYCLOVIR >A> AB PERRIGO UK FINCO 5% A 205659 001 Feb 20, 2019 Feb NEWA ZOVIRAX >A> AB +! BAUSCH 5% N 018604 001 Mar 29, 1982 Feb CAHN >D> AB +! VALEANT BERMUDA 5% N 018604 001 Mar 29, 1982 Feb CAHN ACYCLOVIR; HYDROCORTISONE CREAM;TOPICAL XERESE >A> +! BAUSCH 5%;1% N 022436 001 Jul 31, 2009 Feb CAHN >D> +! VALEANT BERMUDA 5%;1% N 022436 001 Jul 31, 2009 Feb CAHN ALBUTEROL SULFATE TABLET;ORAL ALBUTEROL SULFATE >A> AB APPCO PHARMA LLC EQ 2MG BASE A 207046 001 Jun 29, 2018 Feb CAHN >A> AB EQ 4MG BASE A 207046 002 Jun 29, 2018 Feb CAHN >D> AB RISING PHARMS EQ 2MG BASE A 207046 001 Jun 29, 2018 Feb CAHN >D> AB EQ 4MG BASE A 207046 002 Jun 29, 2018 Feb CAHN ALLOPURINOL TABLET;ORAL ALLOPURINOL >A> AB UNICHEM LABS LTD 100MG A 211820 001 Mar 12, 2019 Feb NEWA >A> AB 300MG A 211820 002 Mar 12, 2019 Feb NEWA ALTRETAMINE CAPSULE;ORAL >D> HEXALEN >D> +! EISAI INC 50MG N 019926 001 Dec 26, 1990 Feb DISC >A> + @ 50MG N 019926 001 Dec 26, 1990 Feb DISC Page 1 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST AMILORIDE HYDROCHLORIDE TABLET;ORAL AMILORIDE HYDROCHLORIDE >D> AB USPHARMA WINDLAS 5MG A 204180 001 Aug 07, 2015 Feb CAHN >A> AB WINDLAS HLTHCARE 5MG A 204180 001 Aug 07, 2015 Feb CAHN AMINOCAPROIC ACID TABLET;ORAL AMICAR >D> AB +! CLOVER PHARMS 1GM N 015197 002 Jun 24, 2004 Feb CHRS >A> AB + 1GM N 015197 002 Jun 24, 2004 Feb CHRS AMINOCAPROIC ACID >D> AB SUNNY PHARMTECH INC 1GM A 209060 002 Nov 27, 2018 Feb CHRS >A> AB ! 1GM A 209060 002 Nov 27, 2018 Feb CHRS AMINOPHYLLINE INJECTABLE;INJECTION AMINOPHYLLINE >D> AP ! HOSPIRA 25MG/ML A 087242 001 Oct 26, 1983 Feb CTEC >A> ! 25MG/ML A 087242 001 Oct 26, 1983 Feb CTEC >D> AP LUITPOLD 25MG/ML A 087600 001 Aug 27, 1981 Feb DISC >A> @ 25MG/ML A 087600 001 Aug 27, 1981 Feb DISC AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE CAPSULE;ORAL AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE >D> AB MYLAN EQ 2.5MG BASE;10MG A 077375 001 May 21, 2010 Feb DISC >A> @ EQ 2.5MG BASE;10MG A 077375 001 May 21, 2010 Feb DISC >D> AB EQ 5MG BASE;10MG A 077375 002 May 21, 2010 Feb DISC >A> @ EQ 5MG BASE;10MG A 077375 002 May 21, 2010 Feb DISC >D> AB EQ 5MG BASE;20MG A 077375 003 May 21, 2010 Feb DISC >A> @ EQ 5MG BASE;20MG A 077375 003 May 21, 2010 Feb DISC >D> AB EQ 5MG BASE;40MG A 079047 001 Jul 05, 2011 Feb DISC >A> @ EQ 5MG BASE;40MG A 079047 001 Jul 05, 2011 Feb DISC >D> AB EQ 10MG BASE;20MG A 077375 004 May 21, 2010 Feb DISC >A> @ EQ 10MG BASE;20MG A 077375 004 May 21, 2010 Feb DISC >D> AB EQ 10MG BASE;40MG A 079047 002 Jul 05, 2011 Feb DISC >A> @ EQ 10MG BASE;40MG A 079047 002 Jul 05, 2011 Feb DISC AMOXICILLIN; CLAVULANATE POTASSIUM TABLET;ORAL AUGMENTIN '875' >D> AB + DR REDDYS LABS INC 875MG;EQ 125MG BASE N 050720 001 Feb 13, 1996 Feb CAHN >A> AB + NEOPHARMA 875MG;EQ 125MG BASE N 050720 001 Feb 13, 1996 Feb CAHN ANASTROZOLE TABLET;ORAL ANASTROZOLE >D> AB FRESENIUS KABI ONCOL 1MG A 090088 001 Jun 28, 2010 Feb CAHN >A> AB FRESENIUS KABI USA 1MG A 090088 001 Jun 28, 2010 Feb CAHN ARIPIPRAZOLE TABLET;ORAL ARIPIPRAZOLE >A> AB ALKEM LABS LTD 2MG A 207105 001 Feb 21, 2019 Feb NEWA >A> AB 5MG A 207105 002 Feb 21, 2019 Feb NEWA >A> AB 10MG A 207105 003 Feb 21, 2019 Feb NEWA >A> AB 15MG A 207105 004 Feb 21, 2019 Feb NEWA >A> AB 20MG A 207105 005 Feb 21, 2019 Feb NEWA >A> AB 30MG A 207105 006 Feb 21, 2019 Feb NEWA ASENAPINE MALEATE TABLET;SUBLINGUAL >D> ASENAPINE MALEATE >D> AB SIGMAPHARM LABS LLC EQ 5MG BASE A 206107 001 Jul 17, 2018 Feb DISC >A> @ EQ 5MG BASE A 206107 001 Jul 17, 2018 Feb DISC >D> AB EQ 10MG BASE A 206107 002 Jul 17, 2018 Feb DISC >A> @ EQ 10MG BASE A 206107 002 Jul 17, 2018 Feb DISC SAPHRIS >D> AB + FOREST LABS LLC EQ 5MG BASE N 022117 001 Aug 13, 2009 Feb CTEC Page 2 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ASENAPINE MALEATE TABLET;SUBLINGUAL SAPHRIS >A> + EQ 5MG BASE N 022117 001 Aug 13, 2009 Feb CTEC >D> AB +! EQ 10MG BASE N 022117 002 Aug 13, 2009 Feb CTEC >A> +! EQ 10MG BASE N 022117 002 Aug 13, 2009 Feb CTEC ATENOLOL; CHLORTHALIDONE TABLET;ORAL ATENOLOL AND CHLORTHALIDONE >A> AB ZYDUS PHARMS USA INC 50MG;25MG A 210028 001 Mar 08, 2019 Feb NEWA >A> AB 100MG;25MG A 210028 002 Mar 08, 2019 Feb NEWA ATORVASTATIN CALCIUM TABLET;ORAL ATORVASTATIN CALCIUM >A> AB LUPIN LTD EQ 10MG BASE A 204991 001 Mar 06, 2019 Feb NEWA >A> AB EQ 20MG BASE A 204991 002 Mar 06, 2019 Feb NEWA >A> AB EQ 40MG BASE A 204991 003 Mar 06, 2019 Feb NEWA >A> AB EQ 80MG BASE A 204991 004 Mar 06, 2019 Feb NEWA >A> AB MSN LABS PVT LTD EQ 10MG BASE A 211933 001 Feb 08, 2019 Feb NEWA >A> AB EQ 20MG BASE A 211933 002 Feb 08, 2019 Feb NEWA >A> AB EQ 40MG BASE A 211933 003 Feb 08, 2019 Feb NEWA >A> AB EQ 80MG BASE A 211933 004 Feb 08, 2019 Feb NEWA ATRACURIUM BESYLATE INJECTABLE;INJECTION ATRACURIUM BESYLATE >A> AP HONG KONG 10MG/ML A 091489 001 Feb 17, 2012 Feb CAHN >D> AP NANJING KING-FRIEND 10MG/ML A 091489 001 Feb 17, 2012 Feb CAHN ATRACURIUM BESYLATE PRESERVATIVE FREE >A> AP HONG KONG 10MG/ML A 091488 001 Feb 17, 2012 Feb CAHN >D> AP NANJING KING-FRIEND 10MG/ML A 091488 001 Feb 17, 2012 Feb CAHN AZACITIDINE POWDER;INTRAVENOUS, SUBCUTANEOUS AZACITIDINE >A> AP LUPIN LTD 100MG/VIAL A 210748 001 Feb 27, 2019 Feb NEWA AZITHROMYCIN TABLET;ORAL AZITHROMYCIN >A> AB BIONPHARMA INC EQ 250MG BASE A 210000 001 Feb 26, 2019 Feb NEWA >A> AB EQ 500MG BASE A 210001 001 Feb 26, 2019 Feb NEWA BALSALAZIDE DISODIUM CAPSULE;ORAL BALSALAZIDE DISODIUM >D> AB MYLAN 750MG A 077807 001 Dec 28, 2007 Feb DISC >A> @ 750MG A 077807 001 Dec 28, 2007 Feb DISC BENAZEPRIL HYDROCHLORIDE TABLET;ORAL BENAZEPRIL HYDROCHLORIDE >D> @ ACTAVIS LABS FL INC 5MG A 076267 001 Feb 11, 2004 Feb CAHN >D> @ 10MG A 076267 002 Feb 11, 2004 Feb CAHN >D> @ 20MG A 076267 003 Feb 11, 2004 Feb CAHN >D> @ 40MG A 076267 004 Feb 11, 2004 Feb CAHN >A> @ HERITAGE PHARMA 5MG A 076267 001 Feb 11, 2004 Feb CAHN >A> @ 10MG A 076267 002 Feb 11, 2004 Feb CAHN >A> @ 20MG A 076267 003 Feb 11, 2004 Feb CAHN >A> @ 40MG A 076267 004 Feb 11, 2004 Feb CAHN BENDAMUSTINE HYDROCHLORIDE POWDER;IV (INFUSION) TREANDA >D> AP +! CEPHALON 25MG/VIAL N 022249 002 May 01, 2009 Feb CTEC >A> +! 25MG/VIAL N 022249 002 May 01, 2009 Feb CTEC >D> AP +! 100MG/VIAL N 022249 001 Mar 20, 2008 Feb CTEC >A> +! 100MG/VIAL N 022249 001 Mar 20, 2008 Feb CTEC Page 3 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST BENZONATATE CAPSULE;ORAL BENZONATATE >A> AA ASCENT PHARMS INC 100MG A 211518 001 Feb 22, 2019 Feb NEWA >A> AA 150MG A 211518 002 Feb 22, 2019 Feb NEWA >A> AA 200MG A 211518 003 Feb 22, 2019 Feb NEWA >D> AA CSPC NBP PHARM CO 100MG A 202765 002 Aug 25, 2017 Feb CAHN >D> AA 200MG A 202765 001 Jul 31, 2015 Feb CAHN >A> AA CSPC OUYI 100MG A 202765 002 Aug 25, 2017 Feb CAHN >A> AA 200MG A 202765 001 Jul 31, 2015 Feb CAHN BENZTROPINE MESYLATE INJECTABLE;INJECTION BENZTROPINE MESYLATE >D> AP LUITPOLD 1MG/ML A 091152 001 Mar 29, 2010 Feb DISC >A> @ 1MG/ML A 091152 001 Mar 29, 2010 Feb DISC BEPOTASTINE BESILATE SOLUTION/DROPS;OPHTHALMIC >A> BEPOTASTINE BESILATE >A> AT APOTEX INC 1.5% A 206066 001 Mar 05, 2019 Feb NFTG BEPREVE >D> +! BAUSCH AND LOMB INC 1.5% N 022288 001 Sep 08, 2009 Feb CFTG >A> AT +! 1.5% N 022288 001 Sep 08, 2009 Feb CFTG BICALUTAMIDE TABLET;ORAL BICALUTAMIDE >D> AB FRESENIUS KABI ONCOL 50MG A 079045 001 May 13, 2010 Feb CAHN >D> AB 50MG A 079045 001 May 13, 2010 Feb CAHN >A> AB FRESENIUS KABI USA 50MG A 079045 001 May 13, 2010 Feb CAHN >A> AB 50MG A 079045 001 May 13, 2010 Feb CAHN BLEOMYCIN SULFATE INJECTABLE;INJECTION BLEOMYCIN SULFATE >A> AP CIPLA EQ 15 UNITS BASE/VIAL A 209439 001 Mar 11, 2019 Feb NEWA BRIMONIDINE TARTRATE SOLUTION/DROPS;OPHTHALMIC BRIMONIDINE TARTRATE >A> AT SOMERSET THERAPS LLC 0.2% A 208992 001 Mar 11, 2019 Feb NEWA BUDESONIDE CAPSULE;ORAL BUDESONIDE >A> AB APPCO PHARMA LLC 3MG A 207367 001 Apr 07, 2017 Feb CAHN >D> AB RISING PHARMS 3MG A 207367 001 Apr 07, 2017 Feb CAHN BUMETANIDE TABLET;ORAL BUMETANIDE >A> AB HERITAGE PHARMA 0.5MG A 074225 001 Apr 24, 1995 Feb CAHN >A> AB 1MG A 074225 002 Apr 24, 1995 Feb CAHN >A> AB 2MG A 074225 003 Apr 24, 1995 Feb CAHN >D> AB IVAX SUB TEVA PHARMS 0.5MG A 074225 001 Apr 24, 1995 Feb CAHN >D> AB 1MG A 074225 002 Apr 24, 1995 Feb CAHN >D> AB 2MG A 074225 003 Apr 24, 1995 Feb CAHN BUPIVACAINE HYDROCHLORIDE INJECTABLE;INJECTION BUPIVACAINE HYDROCHLORIDE >A> AP NOVOCOL HEALTHCARE 0.5% A 211096 001 Feb 19, 2019 Feb NEWA BUSULFAN INJECTABLE;INJECTION BUSULFAN >A> AP ACCORD